Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for COLL

Stock Name	Collegium Pharmaceutical Inc
Ticker	COLL(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US19459J1043
LEI	54930049FXZMTLW8D496

Show aggregate COLL holdings

News associated with COLL

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at HC Wainwright: HC Wainwright upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) to a strong-buy rating in a report released on Monday morning, MarketBeat Ratings reports. The firm currently has $44.00 target price on the specialty pharmaceutical company’s stock. COLL has been the subject of several other reports. Wall Street Zen upgraded Collegium Pharmaceutical from a […] - 2025-08-14 03:00:52
Collegium Pharmaceutical (NASDAQ:COLL) Stock Rating Upgraded by Wall Street Zen: Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Saturday. Separately, Piper Sandler reissued a “neutral” rating and set a $37.00 price objective (up previously from $36.00) on shares of Collegium Pharmaceutical […] - 2025-08-11 04:33:01
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH: Universal Beteiligungs und Servicegesellschaft mbH lifted its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 124,671 shares of the specialty pharmaceutical company’s stock after purchasing an additional 2,895 […] - 2025-07-29 05:22:58
Victory Capital Management Inc. Sells 60,823 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Victory Capital Management Inc. cut its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 10.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 498,713 shares of the specialty pharmaceutical company’s stock after selling 60,823 shares during the quarter. Victory Capital […] - 2025-07-24 04:53:18
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Bank of New York Mellon Corp: Bank of New York Mellon Corp decreased its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.1% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 242,261 shares of the specialty pharmaceutical company’s stock after selling 10,426 shares during the period. Bank of New York Mellon Corp’s holdings in Collegium Pharmaceutical were […] - 2025-07-23 04:42:46
Collegium Pharmaceutical (NASDAQ:COLL) to Repurchase $150.00 million in Outstanding Stock: Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) announced that its Board of Directors has approved a stock repurchase program on Monday, July 7th, RTT News reports. The company plans to buyback $150.00 million in outstanding shares. This buyback authorization allows the specialty pharmaceutical company to repurchase up to 15.4% of its shares through open market […] - 2025-07-09 02:16:45
Collegium Pharmaceutical Breaks Above 200-Day Moving Average - Bullish for COLL: In trading on Monday, shares of Collegium Pharmaceutical Inc (Symbol: COLL) crossed above their 200 day moving average of $31.15, changing hands as high as $31.83 per share. Collegium Pharmaceutical Inc shares are currently trading up about 4.2% on the day. The chart below sho - 2025-07-07 12:54:17
Principal Financial Group Inc. Sells 71,695 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Principal Financial Group Inc. decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,573,356 shares of the specialty pharmaceutical company’s stock after selling 71,695 shares during the quarter. Principal […] - 2025-07-07 05:54:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Illinois Municipal Retirement Fund: Illinois Municipal Retirement Fund lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 8.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,820 shares of the specialty pharmaceutical company’s stock after selling 1,384 shares during the quarter. Illinois Municipal Retirement Fund’s […] - 2025-07-04 05:19:14
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Ritholtz Wealth Management: Ritholtz Wealth Management lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 5.0% during the 1st quarter, Holdings Channel.com reports. The firm owned 32,108 shares of the specialty pharmaceutical company’s stock after selling 1,676 shares during the quarter. Ritholtz Wealth Management’s holdings in Collegium Pharmaceutical were worth $958,000 as of its most […] - 2025-06-18 05:56:50
Exchange Traded Concepts LLC Decreases Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Exchange Traded Concepts LLC cut its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 16.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 62,426 shares of the specialty pharmaceutical company’s stock after selling 12,669 shares during […] - 2025-06-18 05:18:59
Farther Finance Advisors LLC Raises Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Farther Finance Advisors LLC boosted its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.5% in the first quarter, Holdings Channel.com reports. The institutional investor owned 11,091 shares of the specialty pharmaceutical company’s stock after acquiring an additional 477 shares during the period. Farther Finance Advisors LLC’s holdings in Collegium Pharmaceutical were worth […] - 2025-06-18 04:30:54
California State Teachers Retirement System Has $862,000 Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): California State Teachers Retirement System reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 30,093 shares of the specialty pharmaceutical company’s stock after selling 856 shares during the period. California State Teachers Retirement System’s holdings in Collegium Pharmaceutical were […] - 2025-06-11 05:04:51
Wellington Management Group LLP Lowers Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Wellington Management Group LLP reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 22.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 88,591 shares of the specialty pharmaceutical company’s stock after selling 26,049 shares during the period. Wellington Management Group […] - 2025-06-06 05:04:54
Bank of America Corp DE Trims Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Bank of America Corp DE decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 29.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 86,096 shares of the specialty pharmaceutical company’s stock after selling 36,093 shares during the period. Bank of America Corp DE’s holdings in Collegium Pharmaceutical were worth […] - 2025-06-02 04:38:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by ProShare Advisors LLC: ProShare Advisors LLC boosted its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 28.8% in the 4th quarter, Holdings Channel reports. The fund owned 11,196 shares of the specialty pharmaceutical company’s stock after acquiring an additional 2,506 shares during the quarter. ProShare Advisors LLC’s holdings in Collegium Pharmaceutical were worth $321,000 […] - 2025-05-30 05:06:52
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $43.80 Average Price Target from Brokerages: Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five ratings firms that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price […] - 2025-05-21 03:14:51
Voya Investment Management LLC Cuts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Voya Investment Management LLC lessened its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 7.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,923 shares of the specialty pharmaceutical company’s stock after selling 789 shares during the period. Voya […] - 2025-05-13 04:32:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stake Reduced by Hsbc Holdings PLC: Hsbc Holdings PLC decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 3.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 16,879 shares of the specialty pharmaceutical company’s stock after selling 576 shares during the period. Hsbc Holdings PLC’s holdings in Collegium Pharmaceutical were worth $483,000 at the end […] - 2025-05-07 05:00:51
Barclays PLC Grows Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Barclays PLC increased its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 6.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 79,754 shares of the specialty pharmaceutical company’s stock after purchasing an additional 4,702 shares during the […] - 2025-05-01 05:14:59
Raymond James Financial Inc. Buys New Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Raymond James Financial Inc. bought a new stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 84,883 shares of the specialty pharmaceutical company’s stock, valued at approximately $2,432,000. Other hedge funds and […] - 2025-04-30 05:10:55
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Legal & General Group Plc: Legal & General Group Plc lessened its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 1.2% during the 4th quarter, Holdings Channel.com reports. The fund owned 91,309 shares of the specialty pharmaceutical company’s stock after selling 1,084 shares during the period. Legal & General Group Plc’s holdings in Collegium Pharmaceutical were […] - 2025-04-24 06:31:01
Russell Investments Group Ltd. Decreases Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Russell Investments Group Ltd. reduced its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 31.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,649 shares of the specialty pharmaceutical company’s stock after selling 6,223 shares […] - 2025-04-24 04:48:48
JPMorgan Chase & Co. Cuts Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): JPMorgan Chase & Co. lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 70.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 82,691 shares of the specialty pharmaceutical company’s stock after selling 194,513 shares during the […] - 2025-04-24 04:16:59
Collegium Pharmaceutical (NASDAQ:COLL) Rating Lowered to Buy at StockNews.com: Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday. A number of other analysts also recently weighed in on the stock. Needham & Company LLC reissued a “buy” rating and set a […] - 2025-04-21 02:22:45
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Bought by Invesco Ltd.: Invesco Ltd. grew its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 19.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,775,760 shares of the specialty pharmaceutical company’s stock after acquiring an additional 289,335 shares during the quarter. Invesco Ltd. owned about […] - 2025-04-16 04:47:00
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at StockNews.com: StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a research report report published on Friday morning. A number of other equities research analysts also recently weighed in on COLL. Needham & Company LLC reaffirmed a “buy” rating and issued a $46.00 target price on […] - 2025-04-14 02:58:57
Vanguard Group Inc. Sells 63,876 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Vanguard Group Inc. cut its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,282,666 shares of the specialty pharmaceutical company’s stock after selling 63,876 shares during the period. Vanguard Group Inc. […] - 2025-04-11 06:16:58
Corebridge Financial Inc. Sells 1,595 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Corebridge Financial Inc. lowered its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 8.5% during the 4th quarter, HoldingsChannel reports. The fund owned 17,084 shares of the specialty pharmaceutical company’s stock after selling 1,595 shares during the period. Corebridge Financial Inc.’s holdings in Collegium Pharmaceutical were worth $489,000 as of its […] - 2025-04-09 04:38:48
American Century Companies Inc. Has $2.45 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): American Century Companies Inc. trimmed its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 18.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 85,466 shares of the specialty pharmaceutical company’s stock after selling 19,447 […] - 2025-04-08 05:04:48

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc COLL holdings

Date	Number of COLL Shares Held	Base Market Value of COLL Shares	Local Market Value of COLL Shares	Change in COLL Shares Held	Change in COLL Base Value	Current Price per COLL Share Held	Previous Price per COLL Share Held
2026-01-15 (Thursday)	4,717	USD 221,227	USD 221,227	728	USD 35,459	USD 46.8999	USD 46.5701
2026-01-14 (Wednesday)	3,989	USD 185,768	USD 185,768	14	USD -2,170	USD 46.5701	USD 47.28
2026-01-13 (Tuesday)	3,975	USD 187,938	USD 187,938	0	USD -3,458	USD 47.28	USD 48.1499
2026-01-12 (Monday)	3,975	USD 191,396	USD 191,396	0	USD 10,374	USD 48.1499	USD 45.5401
2026-01-09 (Friday)	3,975	USD 181,022	USD 181,022	0	USD -12,879	USD 45.5401	USD 48.7801
2026-01-08 (Thursday)	3,975	USD 193,901	USD 193,901	14	USD 6,704	USD 48.7801	USD 47.26
2026-01-07 (Wednesday)	3,961	USD 187,197	USD 187,197	0	USD 4,159	USD 47.26	USD 46.21
2026-01-06 (Tuesday)	3,961	USD 183,038	USD 183,038	0	USD 2,100	USD 46.21	USD 45.6799
2026-01-05 (Monday)	3,961	USD 180,938	USD 180,938	0	USD 594	USD 45.6799	USD 45.5299
2026-01-02 (Friday)	3,961	USD 180,344	USD 180,344	0	USD -3,050	USD 45.5299	USD 46.2999
2025-12-31 (Wednesday)	3,961	USD 183,394	USD 183,394	0	USD -3,288	USD 46.2999	USD 47.13

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of COLL by Blackrock for IE00B3VWM098

Show aggregate share trades of COLL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2026-01-15 BUY 728 47.105 45.810 45.940 USD 33,444 34.00
2026-01-14 BUY 14 47.860 46.530 46.663 USD 653 33.94
2026-01-08 BUY 14 49.165 47.220 47.415 USD 664 33.71
2025-12-23 SELL -14 49.445 48.640 48.720 USD -682 33.10 Loss of -219 on sale
2025-12-03 SELL -70 48.370 47.280 47.389 USD -3,317 32.08 Loss of -1,071 on sale
2025-12-02 BUY 28 47.695 45.820 46.007 USD 1,288 32.01
2025-11-25 SELL -42 46.480 45.500 45.598 USD -1,915 31.66 Loss of -585 on sale
2025-11-24 SELL -42 45.600 44.615 44.714 USD -1,878 31.59 Loss of -551 on sale
2025-11-17 SELL -154 46.480 43.590 43.879 USD -6,757 31.26 Loss of -1,943 on sale
2025-11-12 SELL -14 47.500 45.000 45.250 USD -634 31.02 Loss of -199 on sale
2025-11-06 SELL -14 41.810 39.080 39.353 USD -551 30.78 Loss of -120 on sale
2025-11-05 SELL -140 36.580 35.255 35.387 USD -4,954 30.75 Loss of -649 on sale
2025-11-04 SELL -28 36.540 35.620 35.712 USD -1,000 30.73 Loss of -140 on sale
2025-11-03 SELL -28 36.575 35.330 35.455 USD -993 30.70 Loss of -133 on sale
2025-10-28 BUY 42 35.410 35.815 35.774 USD 1,503 30.59
2025-10-24 SELL -14 35.300 35.970 35.903 USD -503 30.55 Loss of -75 on sale
2025-10-15 BUY 84 32.880 33.000 32.988 USD 2,771 30.39
2025-10-02 BUY 14 34.280 35.305 35.203 USD 493 30.34
2025-09-30 BUY 28 34.990 35.535 35.481 USD 993 30.29
2025-08-21 SELL -14 39.520 39.530 39.529 USD -553 30.12 Loss of -132 on sale
2025-07-31 BUY 42 29.860 30.680 30.598 USD 1,285 30.08
2025-06-30 SELL -28 29.570 30.150 30.092 USD -843 29.91 Loss of -5 on sale
2025-06-25 SELL -14 29.790 30.230 30.186 USD -423 29.91 Loss of -4 on sale
2025-06-20 SELL -28 29.830 29.970 29.956 USD -839 29.91 Loss of -1 on sale
2025-05-23 BUY 14 28.860 28.990 28.977 USD 406 29.98
2025-05-19 SELL -14 29.830 30.160 30.127 USD -422 30.00 Loss of -2 on sale
2025-05-15 SELL -42 29.340 29.800 29.754 USD -1,250 30.00 Profit of 11 on sale
2025-05-12 SELL -14 29.560 30.460 30.370 USD -425 30.02 Loss of -5 on sale
2025-05-09 SELL -14 28.890 29.660 29.583 USD -414 30.03 Profit of 6 on sale
2025-04-30 SELL -14 26.995 27.539 27.485 USD -385 30.22 Profit of 38 on sale
2025-04-24 SELL -28 26.780 26.940 26.924 USD -754 30.35 Profit of 96 on sale
2025-04-17 SELL -14 27.010 27.775 27.698 USD -388 30.54 Profit of 40 on sale
2025-04-15 SELL -42 27.120 27.570 27.525 USD -1,156 30.61 Profit of 130 on sale
2025-04-14 SELL -42 26.730 27.190 27.144 USD -1,140 30.65 Profit of 147 on sale
2025-04-09 SELL -56 26.370 26.822 26.777 USD -1,500 30.82 Profit of 226 on sale
2025-04-07 SELL -98 27.380 28.365 28.266 USD -2,770 30.92 Profit of 260 on sale
2025-04-04 SELL -140 28.140 28.340 28.320 USD -3,965 30.96 Profit of 369 on sale
2025-03-31 BUY 14 29.850 30.200 30.165 USD 422 31.00
2025-03-19 SELL -28 29.850 30.000 29.985 USD -840 31.11 Profit of 32 on sale
2025-03-14 SELL -84 29.460 30.010 29.955 USD -2,516 31.17 Profit of 102 on sale
2025-03-13 SELL -28 29.100 29.910 29.829 USD -835 31.20 Profit of 38 on sale
2025-03-12 SELL -476 29.630 29.910 29.882 USD -14,224 31.23 Profit of 640 on sale
2025-03-07 SELL -28 28.910 30.010 29.900 USD -837 31.30 Profit of 39 on sale
2025-03-06 SELL -42 29.800 30.020 29.998 USD -1,260 31.33 Profit of 56 on sale
2025-03-03 SELL -14 28.440 29.630 29.511 USD -413 31.47 Profit of 27 on sale
2025-02-28 SELL -84 29.050 31.440 31.201 USD -2,621 31.51 Profit of 26 on sale
2025-02-26 SELL -14 28.350 29.500 29.385 USD -411 31.62 Profit of 31 on sale
2025-02-25 SELL -42 28.820 29.400 29.342 USD -1,232 31.67 Profit of 98 on sale
2025-02-18 BUY 70 29.710 30.140 30.097 USD 2,107 31.87
2025-02-13 BUY 14 30.980 31.050 31.043 USD 435 31.97
2025-02-12 BUY 14 30.530 31.530 31.430 USD 440 32.00
2025-02-11 BUY 42 31.580 31.710 31.697 USD 1,331 32.01
2025-02-06 BUY 126 30.950 31.520 31.463 USD 3,964 32.10
2025-01-27 BUY 14 33.910 34.000 33.991 USD 476 32.10
2024-12-30 BUY 70 28.610 29.100 29.051 USD 2,034 32.30
2024-12-06 BUY 56 29.970 30.510 30.456 USD 1,706 32.51
2024-12-05 BUY 14 29.870 31.070 30.950 USD 433 32.60
2024-12-04 BUY 70 31.120 31.340 31.318 USD 2,192 32.65
2024-11-29 BUY 70 30.500 31.110 31.049 USD 2,173 32.87
2024-11-27 BUY 56 30.710 31.700 31.601 USD 1,770 33.06
2024-11-26 BUY 14 31.190 31.660 31.613 USD 443 33.15
2024-11-21 BUY 70 30.410 30.950 30.896 USD 2,163 33.58
2024-11-20 BUY 42 30.000 30.030 30.027 USD 1,261 33.78
2024-11-18 BUY 168 29.220 29.780 29.724 USD 4,994 34.32
2024-11-12 BUY 112 31.410 32.180 32.103 USD 3,596 34.51
2024-11-08 BUY 70 32.160 34.110 33.915 USD 2,374 34.68
2024-11-07 BUY 210 34.710 35.620 35.529 USD 7,461 34.68
2024-11-06 BUY 28 34.500 35.570 35.463 USD 993 34.69
2024-10-31 BUY 14 34.140 34.640 34.590 USD 484 35.32
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2026-01-15	BUY	728	47.105	45.810	45.940	USD 33,444	34.00
2026-01-14	BUY	14	47.860	46.530	46.663	USD 653	33.94
2026-01-08	BUY	14	49.165	47.220	47.415	USD 664	33.71
2025-12-23	SELL	-14	49.445	48.640	48.720	USD -682	33.10 Loss of -219 on sale
2025-12-03	SELL	-70	48.370	47.280	47.389	USD -3,317	32.08 Loss of -1,071 on sale
2025-12-02	BUY	28	47.695	45.820	46.007	USD 1,288	32.01
2025-11-25	SELL	-42	46.480	45.500	45.598	USD -1,915	31.66 Loss of -585 on sale
2025-11-24	SELL	-42	45.600	44.615	44.714	USD -1,878	31.59 Loss of -551 on sale
2025-11-17	SELL	-154	46.480	43.590	43.879	USD -6,757	31.26 Loss of -1,943 on sale
2025-11-12	SELL	-14	47.500	45.000	45.250	USD -634	31.02 Loss of -199 on sale
2025-11-06	SELL	-14	41.810	39.080	39.353	USD -551	30.78 Loss of -120 on sale
2025-11-05	SELL	-140	36.580	35.255	35.387	USD -4,954	30.75 Loss of -649 on sale
2025-11-04	SELL	-28	36.540	35.620	35.712	USD -1,000	30.73 Loss of -140 on sale
2025-11-03	SELL	-28	36.575	35.330	35.455	USD -993	30.70 Loss of -133 on sale
2025-10-28	BUY	42	35.410	35.815	35.774	USD 1,503	30.59
2025-10-24	SELL	-14	35.300	35.970	35.903	USD -503	30.55 Loss of -75 on sale
2025-10-15	BUY	84	32.880	33.000	32.988	USD 2,771	30.39
2025-10-02	BUY	14	34.280	35.305	35.203	USD 493	30.34
2025-09-30	BUY	28	34.990	35.535	35.481	USD 993	30.29
2025-08-21	SELL	-14	39.520	39.530	39.529	USD -553	30.12 Loss of -132 on sale
2025-07-31	BUY	42	29.860	30.680	30.598	USD 1,285	30.08
2025-06-30	SELL	-28	29.570	30.150	30.092	USD -843	29.91 Loss of -5 on sale
2025-06-25	SELL	-14	29.790	30.230	30.186	USD -423	29.91 Loss of -4 on sale
2025-06-20	SELL	-28	29.830	29.970	29.956	USD -839	29.91 Loss of -1 on sale
2025-05-23	BUY	14	28.860	28.990	28.977	USD 406	29.98
2025-05-19	SELL	-14	29.830	30.160	30.127	USD -422	30.00 Loss of -2 on sale
2025-05-15	SELL	-42	29.340	29.800	29.754	USD -1,250	30.00 Profit of 11 on sale
2025-05-12	SELL	-14	29.560	30.460	30.370	USD -425	30.02 Loss of -5 on sale
2025-05-09	SELL	-14	28.890	29.660	29.583	USD -414	30.03 Profit of 6 on sale
2025-04-30	SELL	-14	26.995	27.539	27.485	USD -385	30.22 Profit of 38 on sale
2025-04-24	SELL	-28	26.780	26.940	26.924	USD -754	30.35 Profit of 96 on sale
2025-04-17	SELL	-14	27.010	27.775	27.698	USD -388	30.54 Profit of 40 on sale
2025-04-15	SELL	-42	27.120	27.570	27.525	USD -1,156	30.61 Profit of 130 on sale
2025-04-14	SELL	-42	26.730	27.190	27.144	USD -1,140	30.65 Profit of 147 on sale
2025-04-09	SELL	-56	26.370	26.822	26.777	USD -1,500	30.82 Profit of 226 on sale
2025-04-07	SELL	-98	27.380	28.365	28.266	USD -2,770	30.92 Profit of 260 on sale
2025-04-04	SELL	-140	28.140	28.340	28.320	USD -3,965	30.96 Profit of 369 on sale
2025-03-31	BUY	14	29.850	30.200	30.165	USD 422	31.00
2025-03-19	SELL	-28	29.850	30.000	29.985	USD -840	31.11 Profit of 32 on sale
2025-03-14	SELL	-84	29.460	30.010	29.955	USD -2,516	31.17 Profit of 102 on sale
2025-03-13	SELL	-28	29.100	29.910	29.829	USD -835	31.20 Profit of 38 on sale
2025-03-12	SELL	-476	29.630	29.910	29.882	USD -14,224	31.23 Profit of 640 on sale
2025-03-07	SELL	-28	28.910	30.010	29.900	USD -837	31.30 Profit of 39 on sale
2025-03-06	SELL	-42	29.800	30.020	29.998	USD -1,260	31.33 Profit of 56 on sale
2025-03-03	SELL	-14	28.440	29.630	29.511	USD -413	31.47 Profit of 27 on sale
2025-02-28	SELL	-84	29.050	31.440	31.201	USD -2,621	31.51 Profit of 26 on sale
2025-02-26	SELL	-14	28.350	29.500	29.385	USD -411	31.62 Profit of 31 on sale
2025-02-25	SELL	-42	28.820	29.400	29.342	USD -1,232	31.67 Profit of 98 on sale
2025-02-18	BUY	70	29.710	30.140	30.097	USD 2,107	31.87
2025-02-13	BUY	14	30.980	31.050	31.043	USD 435	31.97
2025-02-12	BUY	14	30.530	31.530	31.430	USD 440	32.00
2025-02-11	BUY	42	31.580	31.710	31.697	USD 1,331	32.01
2025-02-06	BUY	126	30.950	31.520	31.463	USD 3,964	32.10
2025-01-27	BUY	14	33.910	34.000	33.991	USD 476	32.10
2024-12-30	BUY	70	28.610	29.100	29.051	USD 2,034	32.30
2024-12-06	BUY	56	29.970	30.510	30.456	USD 1,706	32.51
2024-12-05	BUY	14	29.870	31.070	30.950	USD 433	32.60
2024-12-04	BUY	70	31.120	31.340	31.318	USD 2,192	32.65
2024-11-29	BUY	70	30.500	31.110	31.049	USD 2,173	32.87
2024-11-27	BUY	56	30.710	31.700	31.601	USD 1,770	33.06
2024-11-26	BUY	14	31.190	31.660	31.613	USD 443	33.15
2024-11-21	BUY	70	30.410	30.950	30.896	USD 2,163	33.58
2024-11-20	BUY	42	30.000	30.030	30.027	USD 1,261	33.78
2024-11-18	BUY	168	29.220	29.780	29.724	USD 4,994	34.32
2024-11-12	BUY	112	31.410	32.180	32.103	USD 3,596	34.51
2024-11-08	BUY	70	32.160	34.110	33.915	USD 2,374	34.68
2024-11-07	BUY	210	34.710	35.620	35.529	USD 7,461	34.68
2024-11-06	BUY	28	34.500	35.570	35.463	USD 993	34.69
2024-10-31	BUY	14	34.140	34.640	34.590	USD 484	35.32

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of COLL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	61,020	0	88,706	68.8%
2025-09-18	41,541	0	67,794	61.3%
2025-09-17	66,618	0	114,347	58.3%
2025-09-16	133,161	0	194,298	68.5%
2025-09-15	152,551	0	212,478	71.8%
2025-09-12	95,136	0	129,598	73.4%
2025-09-11	110,423	0	246,764	44.7%
2025-09-10	53,467	0	99,007	54.0%
2025-09-09	109,513	0	233,493	46.9%
2025-09-08	206,377	2	311,091	66.3%
2025-09-05	78,137	0	150,749	51.8%
2025-09-04	64,006	6,972	105,811	60.5%
2025-09-03	63,593	0	122,600	51.9%
2025-09-02	101,085	0	159,730	63.3%
2025-08-29	46,433	0	126,235	36.8%
2025-08-28	51,923	0	97,387	53.3%
2025-08-27	31,315	0	75,370	41.5%
2025-08-26	40,930	0	153,664	26.6%
2025-08-25	56,670	0	122,837	46.1%
2025-08-22	35,563	0	123,465	28.8%
2025-08-21	36,265	0	85,499	42.4%
2025-08-20	49,364	15	88,020	56.1%
2025-08-19	63,109	50	120,936	52.2%
2025-08-18	29,505	0	92,255	32.0%
2025-08-15	20,662	0	64,211	32.2%
2025-08-14	87,424	0	118,481	73.8%
2025-08-13	49,958	14	132,123	37.8%
2025-08-12	91,824	0	151,451	60.6%
2025-08-11	129,883	3,211	250,035	51.9%
2025-08-08	83,394	0	319,663	26.1%
2025-08-07	193,676	0	339,687	57.0%
2025-08-06	98,233	0	169,420	58.0%
2025-08-05	32,115	0	70,967	45.3%
2025-08-04	36,300	0	70,243	51.7%
2025-08-01	102,275	0	172,380	59.3%
2025-07-31	35,405	0	66,557	53.2%
2025-07-30	21,992	0	61,112	36.0%
2025-07-29	26,689	0	72,676	36.7%
2025-07-28	22,692	0	82,913	27.4%
2025-07-25	30,500	0	69,126	44.1%
2025-07-24	26,485	0	68,767	38.5%
2025-07-23	24,505	0	67,625	36.2%
2025-07-22	41,446	1,004	84,381	49.1%
2025-07-21	32,627	0	70,693	46.2%
2025-07-18	26,588	14	56,895	46.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE